Ascendis Pharma Cash from Operations (TTM) Analysis

Ascendis Pharma A/S (ASND)

133.20 -0.72 (-0.54%) USD | NASDAQ | May 09, 16:00

133.20 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	-458.38M
December 31, 2023	-505.97M
September 30, 2023	-628.75M
June 30, 2023	-578.27M
March 31, 2023	-533.93M
December 31, 2022	-522.76M
September 30, 2022	-503.74M
June 30, 2022	-528.76M
March 31, 2022	-542.56M
December 31, 2021	-494.15M
September 30, 2021	-445.24M
June 30, 2021	-411.42M
March 31, 2021	-334.77M
December 31, 2020	-310.12M
September 30, 2020	-267.99M
June 30, 2020	-257.87M
March 31, 2020	-201.53M
December 31, 2019	-196.96M
September 30, 2019	-184.73M

Date	Value
June 30, 2019	-171.01M
March 31, 2019	-187.90M
December 31, 2018	-163.90M
September 30, 2018	-144.34M
June 30, 2018	-125.89M
March 31, 2018	-130.20M
December 31, 2017	-107.70M
September 30, 2017	-101.43M
June 30, 2017	-85.04M
March 31, 2017	-72.82M
December 31, 2016	-66.60M
September 30, 2016	-59.60M
June 30, 2016	-56.23M
March 31, 2016	-56.60M
December 31, 2015	-48.23M
September 30, 2015	-47.43M
June 30, 2015	-37.63M
March 31, 2015	-29.06M
December 31, 2014	-24.47M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-628.75M

Minimum

Sep 2023

-171.01M

Maximum

Jun 2019

-403.95M

Average

-451.81M

Median

Cash from Operations (TTM) Benchmarks